Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news


From To
Trump Administration Policies Undermine the Global HIV Response

An open letter by more than 200 HIV scientists, researchers and clinicians denouncing the deterioration of U.S. evidence-based policymaking.

19 October 2018
The health innovation system is ‘broken’ and failing patients

NHS patients are being let down by a global health innovation system which fails to deliver the treatments they need at prices that government can afford, according to a new report led by Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment.

18 October 2018
Desperate border crossings, as Venezuela runs short of HIV drugs

Venezuela's economic meltdown has triggered the biggest exodus of people in modern Latin American history.

03 October 2018
Why Payers Sometimes Restrict Access To Single Tablet Regimens For HIV Patients

Cost-effectiveness analysis suggests that resources are better spent on STRs than MTRs. But, good value for money is not necessarily the same thing as cost savings, at least not in the short term. In fact, it usually implies a positive cost per Quality-Adjusted-Life-Year ratio. In other words, one is spending more to get more.

02 October 2018
UK: Government funding cuts leave sexual health and HIV care at 'breaking point'

Surveys of members of the British Association of Sexual Health and HIV (BASHH) and the British HIV Association (BHIVA) provide new evidence of pressure on over stretched sexual health services and a sector at 'breaking point'.

29 September 2018
BHIVA press release
Britons Pay Hundreds for HIV Drugs. Why Do Americans Pay Thousands?

Britain’s National Health Service far outperforms America’s health care system — for far less money — at keeping H.I.V. patients healthy.

25 September 2018
New York Times
UNAIDS welcomes increase in funding from the Netherlands

UNAIDS welcomes the decision by its third largest donor, the Netherlands, to increase its funding to UNAIDS by more than 20%. The Netherlands will provide US$ 23.3 million in core funding in 2018, compared to US$ 19.2 million in 2017.  

24 September 2018
Forum on China-Africa Cooperation: what it means for health

Investment in health is an essential component of the FOCAC. Whereas some laud China's investment strategy, others deplore that gains to health are hard to track. Andrew Green reports.

21 September 2018
The Lancet (requires free registration)
Scotland: HIV charity saved after government funding u-turn

HIV Scotland feared it would have to shut after losing out on Scottish Government cash earlier in the year, forcing staff lay offs. Now, Public Health Minister Joe FitzPatrick has confirmed the Scottish Government has offered the charity £231,000 over three years.

20 September 2018
Evening Express
A Crazy, Murky System for Pricing HIV Drugs

A new gold-standard triple therapy for H.I.V. has just made its debut in Africa. It costs $75 a year. In the United States, many people with H.I.V. take an almost identical therapy. It costs $39,000 a year. The United States is infamous for its high cost of health care — and HIV medicines are a big part of that.

18 September 2018
New York Times
← First12345...102Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.